New Alert Closed Tuesday Near High of Day

AwesomeStocks Hello! This is an update of our newest alert, BCTX. We are continuing to monitor it for sustainable upside potential. Following yesterday’s alert, BCTX opened at 7.35 and rallied to a high of 7.36, afterwards closing the day at 7.29. BCTX has closed the day higher for the past two consecutive days, a potentially bullish indicator. Furthermore, BCTX has rallied above its 50 day moving average this week presenting a breakout opportunity. Earlier this year, when BCTX rallied above its 50 day moving average, it experienced gains of +91% in a little over a month. Could that happen again? In the event that BCTX continues trending above its 50 day moving average, this could be just the beginning of the renewed breakout. Plus, BCTX has a RSI of 53, suggesting the potential for increased gains. Sadly, cancer cells, “can actively weaken the immune system, thus avoid being detected by the patient’s immune system, allowing them to grow and spread”. “This is a particularly pronounced problem in anergic patients (those unable to develop an immune response) who have very weak immune systems.” As the company explained in their most recent press release: “15 out of 27 (56%) evaluable patients from BriaCell’s combination study were anergic (i.e. weak immune systems). Following the treatment with the Bria-IMT™ combination regimen, 70% of anergic patients and 89% of non-anergic patients showed immune system activation/boost.” “The Bria-IMT™ regimen activated/boosted the immune system and produced clinical benefit in both non-anergic and anergic patients with more (i.e. double) clinical benefit in patients who developed an immune response to Bria-IMT™.” “These observations are particularly meaningful for anergic patients with weakened immune systems who have failed to respond to multiple prior treatments.” Furthermore: “Survival and clinical benefits were observed across multiple subtypes of advanced metastatic breast cancer patients, especially in patients with hormone receptor positive (HR+) cancer, a very large segment of the patient population. No immunotherapies have been shown to work in this group of patients. 8 out of 17 HR+ patients experienced progression-free survival benefits in the BriaCell combination study.” Importantly: “BriaCell has developed Bria-OTS2.0 or Bria-APTC, the next generation (enhanced version) of Bria-OTS™, BriaCell’s off-the-shelf personalized immunotherapy for advanced metastatic breast cancer. It expresses other immune activating cytokine molecules in addition to its immune boosting granulocyte-macrophage colony-stimulating factor (GM-CSF). As expected, Bria-OTS2.0 was significantly more effective than Bria-OTS™ in activating naïve T-cells, potentially suggesting faster acting mechanisms of action and better potency.” As the company notes, “Bria-OTS2.0 may deliver significant clinical efficacy and survival benefits in advanced metastatic breast cancer for the following reasons”: “Dual mechanisms of action to achieve strong immune response and clinical activity: The unique mechanism of action allows both direct activation of T-cells, and indirect activation (i.e., by producing immune activating factors) of the immune cells for a more potent and faster acting anti-tumor activity.” “BriaCell continues to develop Bria-OTS2.0 to enhance the potency of the initial version of Bria-OTS™ which is planned to be used in its upcoming phase I/IIa clinical study. The pre-made design should allow fast and cost-effective treatment of patients within days following a simple, rapid, and inexpensive HLA typing saliva test.” This could be another important growth catalyst for the company. BCTX is positioning itself for increased growth as they further accomplish their plans. Sources: [Presentation]( [BC]( [PR1]( [PR2]( [PR3]( [PR4]( [PR5]( [PR6]( [PR7]( [Website]( [Chart]( Happy Trading! AwesomeStocks Note: We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose. DISCLAIMER You should read and understand this disclaimer in its entirety before joining the website or email/blog list of AwesomeStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help. The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete. The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete. Owners and operators of the Publisher have been compensated twelve thousand five hundred dollars by bank wire transfer on 5/5/23 for the distribution of this advertisement about BCTX dated 5/10/23. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time. You are receiving this report/release because you subscribed to receive it at our website or through a third-party site. All our newsletters include an "unsubscribe" link, and you can remove yourself at any time from our newsletters by clicking on that "unsubscribe" link. You can also contact us at info@AwesomeStocks.com to change your information at any time. By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: www.AwesomeStocks.com/Disclaimer and www.AwesomeStocks.com/Privacy-Policy By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. Our records indicate that {EMAIL} requested and confirmed to be added to AwesomeStocks.com on March 5, 2023. [Click Here To Unsubscribe]( 6020 Bent Pine Dr Orlando Florida 32822 USA [Unsubscribe]( | [Change Subscriber Options](